13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q2 2020. See the latest, Q2 2026 →
Reported value
$23.14B
+20% on the quarter before
Positions
72
25 new · 17 sold out
Top 10
44.3%
of the value
Est. gain
+$2.97B
on stocks held all quarter
Est. return
+24.8%
on those stocks since Q1 2020
Positions as of Jun 30, 2020, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2020. Striped tiles are options.
Largest buys
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- American Express Co~$630.1MAdded · 1.7% → 4.3%+6,619,218 shares
- Thermo Fisher Scientific Inc~$628.4MNew · 0.0% → 2.7%+1,734,144 shares
- Aon Plc~$569.3MNew · 0.0% → 2.5%+2,956,029 shares
- Hilton Worldwide Hldgs Inc~$534.2MNew · 0.0% → 2.3%+7,272,455 shares
- Comcast Corp New~$414.0MAdded · 3.2% → 4.8%+10,620,893 shares
- Api Group Corp~$405.0MNew · 0.0% → 1.8%+33,333,333 shares
- Fidelity Natl Information Sv~$390.8MAdded · 2.4% → 3.9%+2,914,473 shares
- Las Vegas Sands Corp~$365.7MAdded · 0.7% → 2.2%+8,030,972 shares
- Nuance Communications Inc~$323.9MNew · 0.0% → 1.4%+12,799,556 shares
- Moody's Corporation~$268.5MNew · 0.0% → 1.2%+977,348 shares
Largest sells
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Netflix~$1.05BCut · 5.2% → 0.7%−2,302,698 shares
- Amazon~$737.2MCut · 8.9% → 7.3%−267,207 shares
- Jd.Com Inc~$637.4MCut · 4.0% → 2.1%−10,592,021 shares
- Lowes Cos Inc~$508.0MCut · 2.5% → 1.0%−3,759,784 shares
- Boston Scientific Corp~$469.0MCut · 5.4% → 2.8%−13,358,924 shares
- Anthem Inc~$411.1MSold out · 2.1% → 0.0%−1,810,632 shares
- Aon Plc~$378.0MSold out · 2.0% → 0.0%−2,290,520 shares
- Alphabet~$363.9MSold out · 1.9% → 0.0%−313,179 shares
- Meta~$335.1MSold out · 1.7% → 0.0%−2,009,125 shares
- MercadoLibre~$315.4MCut · 1.0% → 0.3%−319,941 shares
Holdings
As of Jun 30, 2020. Changes are in shares against Mar 31, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AmazonCOM · shares −30% · price +41.5% | 7.3% | $1.69B | +$495.9M | ||||||||
| Adaptive Biotechnologies CorCOM · shares 0% · price +74.2% | 7.0% | $1.62B | +$690.0M | ||||||||
| Comcast Corp NewCL A · shares +59% · price +13.4% | 4.8% | $1.11B | +$82.4M | ||||||||
| Centene Corp DelCOM · shares −0.8% · price +7.0% | 4.4% | $1.02B | +$66.7M | ||||||||
| American Express CoCOM · shares +171% · price +11.2% | 4.3% | $999.4M | +$37.2M | ||||||||
| Fidelity Natl Information SvCOM · shares +77% · price +10.2% | 3.9% | $900.3M | +$47.3M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price +12.4% | 3.8% | $868.1M | +$96.1M | ||||||||
| MicrosoftCOM · shares −24% · price +29.0% | 3.3% | $755.2M | +$169.9M | ||||||||
| Boston Scientific CorpCOM · shares −42% · price +7.6% | 2.8% | $648.0M | +$45.8M | ||||||||
| Thermo Fisher Scientific IncCOM · shares New | 2.7% | $628.4M | — | ||||||||
| Jpmorgan Chase & CoCOM · shares +57% · price +4.5% | 2.6% | $603.1M | +$16.5M | ||||||||
| Fortive CorpCOM · shares −7.0% · price +22.6% | 2.6% | $592.7M | +$109.2M | ||||||||
| Aon PlcSHS CL A · shares New | 2.5% | $569.3M | — | ||||||||
| Cigna Corp NewCOM · shares +16% · price +5.9% | 2.4% | $553.5M | +$26.7M | ||||||||
| Hilton Worldwide Hldgs IncCOM · shares New | 2.3% | $534.2M | — | ||||||||
| UberCOM · shares −37% · price +11.3% | 2.2% | $511.9M | +$52.0M | ||||||||
| Las Vegas Sands CorpCOM · shares +260% · price +7.2% | 2.2% | $506.6M | +$9.5M | ||||||||
| Jd.Com IncSPON ADR CL A · shares −56% · price +48.6% | 2.1% | $497.5M | +$162.7M | ||||||||
| Api Group CorpCOM STK · shares New | 1.8% | $405.0M | — | ||||||||
| SalesforceCOM · shares −39% · price +30.1% | 1.7% | $401.9M | +$93.0M | ||||||||
| T-Mobile Us IncCOM · shares +203% · price +24.1% | 1.7% | $395.7M | +$25.4M | ||||||||
| Nuance Communications IncCOM · shares New | 1.4% | $323.9M | — | ||||||||
| Booking Holdings IncCOM · shares +8.5% · price +18.4% | 1.4% | $322.8M | +$46.2M | ||||||||
| Assurant IncCOM · shares +32% · price −0.8% | 1.3% | $291.9M | −$1.7M | ||||||||
| Ingersoll Rand IncCOM · shares −15% · price +13.4% | 1.2% | $286.7M | +$33.9M | ||||||||
| Total · 72 positions | 100% | $23.14B | +$2.97B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2020 to Q2 2020: 47 stocks held throughout, up $2.97B (+24.8%).
- Adaptive Biotechnologies Cor+$690.0M+74%
- Amazon+$495.9M+41%
- Microsoft+$169.9M+29%
- Jd.Com Inc+$162.7M+49%
- Fortive Corp+$109.2M+23%
- Assurant Inc−$1.7M−1%
- Encompass Health Corp−$3.0M−3%
- Bristol-Myers Squibb Co−$4.2M−6%
- Cme Group Inc−$5.0M−6%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |